CASE STUDY 1

Opportunity Assessment and Asset Prioritization

Axiom's Role

Situation.png

1

Problem_1ldpi.png

2

3

Biotech was developing a novel PET imaging agent and needed to understand the overall market potential

Their imaging agent would require a shift in patient management and could be utilized at various stages of disease

Company did not have the resources and internal expertise to conduct market research and develop a model

Solution.png
Solutionldpi.png

Axiom developed a model to track patients from early- through late-stage disease enabling understanding of the true market opportunity based on detailed primary and secondary research

We additionally helped support due diligence during acquisition negotiations

Delivered for Client

Case1_photo2.png
Case1_photo1.png

THE PROJECT TEAM

Jonathan Yoder.png
  • LinkedIn

Jon Yoder

Managing Director

"This project was a fun challenge that produced a unique solution"

For more information contact

WHAT MADE THIS SPECIAL

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

TITLE

TITLE

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.